Xact Kapitalforvaltning’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$1.41M Hold
24,232
0.03% 414
2019
Q4
$2.24M Buy
24,232
+2,207
+10% +$194K 0.04% 389
2019
Q3
$1.99M Buy
22,025
+2,400
+12% +$273K 0.04% 386
2019
Q2
$2.32M Hold
19,625
0.05% 350
2019
Q1
$1.7M Sell
19,625
-800
-4% -$68.1K 0.04% 418
2018
Q4
$1.29M Buy
20,425
+1,700
+9% +$117K 0.03% 460
2018
Q3
$1.48M Buy
18,725
+800
+4% +$52.2K 0.03% 479
2018
Q2
$1.07M Buy
17,925
+1,600
+10% +$86.1K 0.02% 563
2018
Q1
$658K Buy
16,325
+4,800
+42% +$234K 0.01% 694
2017
Q4
$606K Buy
+11,525
New +$615K 0.01% 628

Other funds holding EXAS

Xact Kapitalforvaltning's EXAS Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Exact Sciences (EXAS) position steady in Q1 2020 at 24,232 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #414.

Xact Kapitalforvaltning first reported a position in EXAS in Q4 2017 and has held it in 10 quarters since. The position peaked at $2.32M in Q2 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Xact Kapitalforvaltning held 24,232 shares of Exact Sciences worth $1.41M as of Q1 2020.
  • Xact Kapitalforvaltning left its Exact Sciences share count unchanged in Q1 2020.
  • Exact Sciences made up 0.03% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #414 holding.
  • Xact Kapitalforvaltning first reported a position in Exact Sciences in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's Exact Sciences position peaked at $2.32M in Q2 2019.
  • 476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.